Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 5/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23922522 | 0.89 | TSHR (0.60) | TSHRALDH1A1MTNR1AMTNR1BKDM4E | |
| SCHEMBL22814923 | 0.85 | TSHR (0.44) | TSHRALDH1A1MTNR1AMTNR1BKDM4E | |
| SCHEMBL22814968 | 0.83 | TSHR (0.43) | TSHRALDH1A1MTNR1AMTNR1BKDM4E | |
| SCHEMBL17164980 | 0.81 | ADRA1A (0.55) | TSHRALDH1A1MTNR1AMTNR1BKDM4E | |
| SCHEMBL22814925 | 0.81 | TSHR (0.41) | TSHRALDH1A1MTNR1AMTNR1BKDM4E | |
| SCHEMBL17169898 | 0.80 | TSHR (0.40) | TSHRALDH1A1MTNR1AMTNR1BKDM4E | |
| SCHEMBL16260817 | 0.79 | TSHR (0.54) | TSHRALDH1A1MTNR1AMTNR1BKDM4E | |
| SCHEMBL25587742 | 0.78 | TSHR (0.56) | TSHRALDH1A1KDM4EKMT2ACA12 | |
| SCHEMBL18734790 | 0.78 | TSHR (0.62) | TSHRALDH1A1MTNR1AMTNR1BKDM4E | |
| SCHEMBL15241525 | 0.78 | ZDHHC7 (0.54) | TSHRALDH1A1MTNR1AMTNR1BKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113993842-B | Succinate prodrugs, compositions comprising succinate prodrugs and uses thereof | 爱博利瓦有限公司 | 2024-07-16 | — | — | CN | claimed |
| EP-4360708-A2 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | Abliva AB (SE) | 2024-05-01 | — | — | EP | claimed |
| EP-3986862-B1 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | Abliva Ab (SE) | 2024-01-24 | — | — | EP | claimed |
| US-20230033294-A1 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | Abliva Ab (SE) | 2023-02-02 | — | — | US | claimed |
| US-11565998-B2 | Succinate prodrug, compositions containing the succinate prodrug and uses thereof | Abliva Ab (SE) | 2023-01-31 | — | — | US | claimed |
| US-20220162162-A1 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | Abliva Ab (SE) | 2022-05-26 | — | — | US | claimed |
| EP-3986862-A1 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | Abliva AB (SE) | 2022-04-27 | — | — | EP | claimed |
| WO-2020254484-A1 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | Abliva Ab (SE) | 2020-12-24 | — | — | WO | claimed |
| JP-2025004155-A | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING SUCCINATE PRODRUG AND USES THEREOF | アブリバ エービー | 2025-01-14 | — | — | JP | disclosed |
| US-12162824-B2 | Succinate prodrug, compositions containing the succinate prodrug and uses thereof | Abliva Ab (SE) | 2024-12-10 | — | — | US | disclosed |
| CN-113993842-B | Succinate prodrugs, compositions comprising succinate prodrugs and uses thereof | 爱博利瓦有限公司 | 2024-07-16 | — | — | CN | disclosed |
| EP-4360708-A2 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | Abliva AB (SE) | 2024-05-01 | — | — | EP | disclosed |
| EP-3986862-B1 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | Abliva Ab (SE) | 2024-01-24 | — | — | EP | disclosed |
| EP-3986862-B1 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | Abliva Ab (SE) | 2024-01-24 | — | — | EP | disclosed |
| US-20220162162-A1 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | Abliva Ab (SE) | 2022-05-26 | — | — | US | disclosed |
| US-20220162162-A1 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | Abliva Ab (SE) | 2022-05-26 | — | — | US | disclosed |
| EP-3986862-A1 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | Abliva AB (SE) | 2022-04-27 | — | — | EP | disclosed |
| CN-113993842-A | Succinate prodrugs, compositions comprising succinate prodrugs and uses thereof | 爱博利瓦有限公司 | 2022-01-28 | — | — | CN | disclosed |
| WO-2020254484-A1 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | Abliva Ab (SE) | 2020-12-24 | — | — | WO | disclosed |
| WO-2020254484-A1 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | Abliva Ab (SE) | 2020-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162162-A1 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | CS, SLC25A1, SLC8B1 | TSHR 4547/4885ALDH1A1 1333/4885MTNR1A 1083/4885 |
| US-11565998-B2 | Succinate prodrug, compositions containing the succinate prodrug and uses thereof | CS, SLC25A1, SLC8B1 | TSHR 4547/4885ALDH1A1 1333/4885MTNR1A 1083/4885 |
| US-12162824-B2 | Succinate prodrug, compositions containing the succinate prodrug and uses thereof | CS, SLC25A1, SUCNR1 | TSHR 4628/4885ALDH1A1 1362/4885MTNR1A 967/4885 |
| US-20230033294-A1 | SUCCINATE PRODRUG, COMPOSITIONS CONTAINING THE SUCCINATE PRODRUG AND USES THEREOF | CS, SLC25A1, SUCNR1 | TSHR 4628/4885ALDH1A1 1362/4885MTNR1A 967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.